Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).

Publication ,  Journal Article
Cox, DA; Stone, GW; Grines, CL; Stuckey, T; Zimetbaum, PJ; Tcheng, JE; Turco, M; Garcia, E; Guagliumi, G; Iwaoka, RS; Mehran, R; O'Neill, WW ...
Published in: Am J Cardiol
August 1, 2006

We determined the outcomes of patients with acute ST-segment elevation (STE) myocardial infarction (STEMI) and non-STEMI (NSTEMI) after primary percutaneous coronary intervention (PCI). The prognosis after primary PCI in STEMI has been extensively studied and defined. Outcomes of patients who undergo primary PCI for NSTEMI are less well established. In total, 2,082 patients with ongoing chest pain for > 30 minutes consistent with acute MI were randomized to balloon angioplasty versus stenting, each with/without abciximab. Of 1,964 patients, STEMI was present in 1,725 (87.8%) and NSTEMI in 239 (12.2%). Compared with STEMI, those with NSTEMI were more likely to have delayed time-to-hospital arrival (2.4 vs 1.8 hours, p = 0.0002) and increased door-to-balloon time (3.2 vs 1.9 hours, p < 0.0001). Patients with NSTEMI were more likely to have Thrombolysis In Myocardial Infarction grade 3 flow at baseline (37.3% vs 19.4%, p < 0.0001) and higher ejection fraction (58.7% vs 55.8%, p = 0.001), but similar rates of postprocedural Thrombolysis In Myocardial Infarction grade 3 flow. At 1 year, patients with NTEMI had similar mortality (3.4% vs 4.4%, p = 0.40) but higher rates of major adverse cardiac events (24.0% vs 16.6%, p = 0.007) that was driven by more frequent ischemic target vessel revascularization (21.8% vs 11.9%, p <0.0001). In conclusion, patients with acute MI without STE who are treated with primary PCI have marked delays to treatment, similar late mortality, and increased rates of ischemic target vessel revascularization compared with patients with STEMI, despite more favorable angiographic features at presentation and similar reperfusion success. The adverse prognosis of patients with NSTEMI should be recognized and efforts made to decrease reperfusion times.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Cardiol

DOI

ISSN

0002-9149

Publication Date

August 1, 2006

Volume

98

Issue

3

Start / End Page

331 / 337

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Time Factors
  • Survival Rate
  • Stroke Volume
  • Stents
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Immunoglobulin Fab Fragments
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cox, D. A., Stone, G. W., Grines, C. L., Stuckey, T., Zimetbaum, P. J., Tcheng, J. E., … CADILLAC Investigators, . (2006). Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial). Am J Cardiol, 98(3), 331–337. https://doi.org/10.1016/j.amjcard.2006.01.102
Cox, David A., Gregg W. Stone, Cindy L. Grines, Thomas Stuckey, Peter J. Zimetbaum, James E. Tcheng, Mark Turco, et al. “Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).Am J Cardiol 98, no. 3 (August 1, 2006): 331–37. https://doi.org/10.1016/j.amjcard.2006.01.102.
Cox DA, Stone GW, Grines CL, Stuckey T, Zimetbaum PJ, Tcheng JE, Turco M, Garcia E, Guagliumi G, Iwaoka RS, Mehran R, O’Neill WW, Lansky AJ, Griffin JJ, CADILLAC Investigators. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial). Am J Cardiol. 2006 Aug 1;98(3):331–337.
Journal cover image

Published In

Am J Cardiol

DOI

ISSN

0002-9149

Publication Date

August 1, 2006

Volume

98

Issue

3

Start / End Page

331 / 337

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Time Factors
  • Survival Rate
  • Stroke Volume
  • Stents
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Immunoglobulin Fab Fragments